Anti-inflammatory dietary compounds, inflammation biomarkers and cardiometabolic risk factors

POPELKA R; DEFAGO MD; CARRIZO L; PEDERNERA C; PEROVIC NR; DISERIO G

Buenos Aires

Congreso; IUNS 21st International Congress of Nutrition; 2017

Sociedad Argentina de Nutrición

Background and objectives: Dietary phenolic compounds (PC) are involved in regulation of inflammatory processes such as in cardiometabolic diseases (CMD). The aim was to analyze the association between dietary PC, inflammatory biomarkers and risk factors of CMD. Methods: Observational and correlational study. Participated 120 adults, both sex (60 women and 60 men), attended at the Non-Invasive Cardiology Division of the National Hospital of Clinics, Córdoba, Argentina, period 2014-2016. A clinical history, a validated food intake questionnaire, a physical activity questionnaire, smoking habits, systolic (SBP) and diastolic (DBP) blood pressure, nutritional status, waist circumference (WC), triglycerides (TG), serum lipid profile (total cholesterol, HDLc and LDLc) and ultrasensitive C-reactive protein (hs-CRP) were evaluated. Interfood v.1.3 software was employed to estimate fruits, vegetables and PC (isoflavones, flavones, flavonones, flavonols, flavanones, anthocyanins) intake. Spearman correlation test was used for thecorrelation analysis. Results: Average age was 61±1.43 years old, body mass-index(BMI) 28.76 ± 0.96 kg/m2 and WC 100.50 ± 2.35 cm. About risk factors, BMI was associated with SBP and DBP (r=0.22, p